Table 1 EORTC HLQLQ C-30 and PR-25 module ratings over 3 years, m (sd) (n = 21)
From: Daily life and life quality 3 years following prostate cancer treatment
Year/Test | 1 | 2 | Wilcoxon1) | 3 | Friedman2) |
|---|---|---|---|---|---|
Physical functioning | 94.8 (7.4) | 90.0 (19.7) | 92.1 (13.8) | ||
Role functioning | 93.3 (13.7) | 91.2 (24.4) | 91.7 (23.6) | ||
Emotional functioning | 80.2 (16.8) | 77.2 (20.8) | 77.5 (22.0) | ||
Cognitive functioning | 84.9 (15.7) | 80.7 (23.7) | 83.3 (23.6) | ||
Social functioning | 81.1 (23.5) | 80.0 (21.9) | 78.4 (21.9) | ||
Global Health/QLQ | 74.6 (23.6) | 82.0 (17.2) | <0.001 | 81.9 (21.9) | <0.001 |
Fatigue | 17.4 (23.2) | 21.6 (24.7) | 20.9 (17.7) | ||
Pain | 7.5 (18.7) | 8.9 (19.5) | 6.9 (14.5) | ||
Nausea/vomiting | 3.9 (8.9) | 2.6 (8.4) | 3.9 (7.3) | ||
Dyspnoea | 9.5 (15.4) | 17.5 (20.4) | <0.03 | 19.6 (23.7) | <0.015 |
Appetite loss | 7.9 (20.8) | 12.3 (31.8) | 9.8 (25.7) | ||
Insomnia | 16.6 (20.2) | 20.4 (28.3) | 17.6 (26.7) | ||
Constipation | 14.3 (27.0) | 7.0 (17.8) | 5.8 (13.1) | ||
Diarrhoea | 3.2 (10.0) | 7.0 (14.0) | 7.8 (14.6) | ||
Financial difficulties | - | 10.5 (27.3) | 5.8 (13.1) | ||
Sexual activity | 27.8 (23.1) | 33.3 (29.7) | 28.4 (20.2) | ||
Sexual functioning | 71.7 (29.1) | 61.5 (21.3) | 38.9 (20.5) | <0.008 | |
Urinary symptoms | 28.3 (29.2) | 21.9 (22.5) | 20.2 (16.6) | <0.05 | |
Bowel symptoms | 11.3 (14.1) | 11.7 (16.3) | 12.8 (18.8) | ||
Hormon treatm. related symptoms | 17.1 (16.1) | 21.2 (13.3) | 17.8 (10.1) | ||
Incontinence aid | 33.3 (−) | 55.6 (38.5) | 11.1 (27.2) |